Use of human chorionic gonadotropin in the treatment in the treatment of symptoms endometriosis
OA: closed
AI-generated summary
This study identifies human chorionic gonadotropin as an efficient agent for treating endometriosis-related symptoms, including chronic pelvic pain, pre-menstrual syndrome, dysmenorrhea, dyspareunia, and infertility.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The human chorionic gonadotropin is found to be a new, efficient agent for the treatment of symptoms like chronic pelvic pain, pre-menstrual syndrom, dysmenorrhea, dyspareunia and infertility, caused by endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-15T06:11:00.801789+00:00